-
Inhibitors for Cancer Treatment: From Concept to Clinic | IntechOpen
ID: YHIaajSOkf
From: intechopen.com
-
influence of metabolism CYP17A1 inhibitor activity | Nature Urology
ID: eu3GZVDNiD
From: nature.com
-
Stepwise of inhibitors to human cytochrome P450 17A1 and rapid kinetics of inhibition of androgen biosynthesis - Journal of Biological Chemistry
ID: 2fpkjBZwfQ
From: jbc.org
-
CYP17 inhibitors for prostate therapy - ScienceDirect
ID: KnfxyA6fJP
From: sciencedirect.com
-
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence castration-resistant prostate cancer | British Journal of Cancer
ID: Ufa40vjotR
From: nature.com
-
Abiraterone acetate
ID: n0nAnzw0nk
From: en.wikipedia.org
-
Herzogin Aggressiv Leiden cyp 17 inhibitors nature Interessant Annäherung
ID: ZM8BdtRs3h
From: earthinnovation.org
-
Inhibitors for Cancer Treatment: From Concept to Clinic | IntechOpen
ID: cANlUs4J6L
From: intechopen.com
-
Enzymatic reaction catalyzed by CYP17. CYP17 catalyzes two... | Download Diagram
ID: zWgEGPcDGT
From: researchgate.net
-
Effects of 17α-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen in vitro in - ScienceDirect
ID: KJCeXOF06y
From: sciencedirect.com
-
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting Nature Reviews Urology
ID: l3O7xId3SZ
From: nature.com
-
Frontiers | Second-Generation Antiandrogens: From Discovery to of Care in Castration Resistant Prostate Cancer | Oncology
ID: 6TgbMXlCNY
From: frontiersin.org
-
Inhibitors for Cancer Treatment: From Concept to Clinic | IntechOpen
ID: Lo6BOpp6Tv
From: intechopen.com
-
References in Functional characterization of mutant CYP17 genes isolated a 17α-hydroxylase/17,20-lyase-deficient patient - Metabolism - Clinical and
ID: 39Y9d1puAN
From: metabolismjournal.com
-
Inhibitors for Cancer Treatment: From Concept to Clinic | IntechOpen
ID: a0vN5R0QJX
From: intechopen.com
-
JAK inhibition as a therapeutic for immune and inflammatory diseases | Nature Reviews Drug
ID: pVAskEPZ1i
From: nature.com
-
population pharmacokinetic analysis of the oral CYP17 lyase and receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate or cancer | Request PDF
ID: nM1dC7VrVx
From: researchgate.net
-
Ginsenoside F1 | ≥99%(HPLC) | Selleck | P450 CYP17) inhibitor
ID: NRKTplARvq
From: selleckchem.com
-
Targeting IL-17–TH17 pathway | Reviews Drug Discovery
ID: 7QhjwYsVCC
From: nature.com
-
Inhibitors for Cancer Treatment: From Concept to Clinic | IntechOpen
ID: cDGSORFNW1
From: intechopen.com
-
Resistance to receptor antagonists prostate cancer Nature Reviews Urology
ID: BcffwxH0td
From: nature.com
-
Inhibitors for Cancer Treatment: From Concept to Clinic | IntechOpen
ID: QZgO2vZDxU
From: intechopen.com
-
Targeting of CYP17A1 Lyase by Inhibits Adrenal and Intratumoral and Tumor Growth of Castration Resistant Prostate Cancer | Scientific Reports
ID: wyk5BfVdO6
From: nature.com
-
Mechanisms of resistance to CYP17 Androgen receptor (AR)... | Download Diagram
ID: I1Si32BV2R
From: researchgate.net